Sanofi ditches mRNA COVID-19 vaccine after rivals’ success

PARIS (Reuters) -Sanofi is dropping plans for its own mRNA-based COVID-19 vaccine because of the dominance achieved by BioNTech-Pfizer and Moderna (NASDAQ:MRNA) in using the technology to...